🎉📢 VantAI will be at #icml2024! We'll be co-hosting the AI x Bio/Chem social of the week together with our friends from Microsoft AI4Science and Relation. Come join us in Vienna after the ML4LMS workshop on 📆 Friday July 26th 📆 for an evening of fun, networking, great food and great drinks. Including an AI-Drug Discovery myth-busting session featuring Michael Bronstein, Luca Naef, Lindsay Edwards, Anthony Costa and Marwin Segler. Register here: https://lu.ma/rojc95k1
About us
VantAI pairs bleeding-edge machine learning techniques with deep systems biology expertise to build computational models that uncover hidden relationships between molecules, targets, and diseases. These models power a best-in-class solution that identifies and generates new molecular entities for targets of interest, repurposes existing molecules at any stage of development, uncovers accurate ADME and toxicological insights, and predicts adverse events likely to influence trial success from deep analysis of systems-based pharmacogenomics. VantAI's in silico platform specializes in modelling complex protein-protein interactions, powering the discovery of biologics and protein degraders in addition to small-molecule drugs. It has helped leading biopharma partners launch new development programs--or revitalize old ones--at a fraction of the time and cost of traditional methods. For more information, please visit http://www.vant.ai.
- Website
-
http://www.vant.ai
External link for VantAI
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 2019
Locations
-
Primary
Get directions
New York, NY 10003, US
Employees at VantAI
-
Michael Bronstein
DeepMind Professor of AI, Oxford / Serial startupper
-
Zeenat Patrawala
Chief Business Officer | AI Advisor |Google AI | MIT| Cornell | Advocate for Women
-
John Cuozzo
SVP, Head of Drug Discovery at VantAI
-
Alexander Goncearenco
Modulating protein-protein interactions to cure diseases and cancer
Updates
-
Francesco Di Giovanni and Kacper Kapusniak's talk on Metric Flow Matching is now live on our YouTube channel. https://lnkd.in/eHTQqjvy
Metric Flow Matching | Kacper Kapusniak, Francesco Di Giovanni
https://www.youtube.com/
-
⏰ 1 hour to go!
💥 Happening in 10 days! 📷 Francesco Di Giovanni and Kacper Kapusniak will talk about their recent paper on Metric Flow Matching (MFM), a novel generative approach using data-induced Riemannian metrics for more accurate interpolations. Hosted by Michael Bronstein and Bruno Correia 📅 Fri, Jul 05, 2024; 11am ET / 5pm CET / 8am PST Sign-up link in comments.
-
-
Join us this Friday, July 5th, at 11am ET / 5pm CET / 8am PST, when Francesco Di Giovanni and Kacper Kapusniak will give an exciting talk about their new work on Metric Flow Matching (MFM).
💥 Happening in 10 days! 📷 Francesco Di Giovanni and Kacper Kapusniak will talk about their recent paper on Metric Flow Matching (MFM), a novel generative approach using data-induced Riemannian metrics for more accurate interpolations. Hosted by Michael Bronstein and Bruno Correia 📅 Fri, Jul 05, 2024; 11am ET / 5pm CET / 8am PST Sign-up link in comments.
-
-
💥 Happening in 10 days! 📷 Francesco Di Giovanni and Kacper Kapusniak will talk about their recent paper on Metric Flow Matching (MFM), a novel generative approach using data-induced Riemannian metrics for more accurate interpolations. Hosted by Michael Bronstein and Bruno Correia 📅 Fri, Jul 05, 2024; 11am ET / 5pm CET / 8am PST Sign-up link in comments.
-
-
VantAI reposted this
If you're at New York Tech Week and interested AI x Bio/Medicine, there's a great event tomorrow featuring NVIDIA, VAST Data and myself from VantAI at the beautiful new West End Labs! https://lnkd.in/ebVmXdHx #NYTechWeek #Techweek #NYTW
The Next Chapter in AI-Powered Life Sciences and Research
vastdata.com
-
Two more puzzle pieces fall into place today as industry and academic titans join our stellar Scientific Advisory Board at VantAI! 🚀 🚀 🚀 Dr. Ian Churcher and Dr. Brad L. Pentelute are pioneers in their respective fields, and each brings unique and powerful capabilities, knowledge, and experience to VantAI's mission to reframe the way we treat disease. Building models that enable the systematic re-wiring of protein interactions requires deep expertise in a wide range of data generation technologies, as well as the drug development experience needed to bring the fruits of these efforts to patients in need. We are thrilled to team up with these two incredible scientists and can't wait to unveil the exciting developments happening behind the scenes... Stay tuned! 📈 Fan Liu Bruno Correia Philippe Schwaller VantAI #AI #Techbio #DrugDiscovery #Biotech #inducedproximity #ML #TPD #molecularglues #protac #proteomics
-
-
VantAI reposted this
Gabriele Corso's talk about problems with existing docking benchmarks and novel strategies to improve docking generalization through scaling, synthetic data, and a new self-training paradigm called confidence bootstrapping is now live on our YouTube channel https://lnkd.in/ev9Dd4YF
Deep Confident Steps to New Pockets: Strategies for Docking Generalization | Gabriele Corso
https://www.youtube.com/
-
Gabriele Corso's talk about problems with existing docking benchmarks and novel strategies to improve docking generalization through scaling, synthetic data, and a new self-training paradigm called confidence bootstrapping is now live on our YouTube channel https://lnkd.in/ev9Dd4YF
Deep Confident Steps to New Pockets: Strategies for Docking Generalization | Gabriele Corso
https://www.youtube.com/
-
Join us in 10 minutes! 🚀
📢 Excited to announce the next speaker: 🗣️ Gabriele Corso will talk about his recent work on assessing and addressing generalization in protein-ligand docking 📅 May 17th, 2024; 11am ET / 5pm CET / 8am PST Sign up https://lnkd.in/e42FCCT9 As always, moderated by Michael Bronstein and Bruno Correia
-